CD163 and ovarian carcinoma: To test this hypothesis, the potential codistribution between HMGCR and TAMs was investigated in serial sections of ovarian cancer tissue microarrays of 252 cores by IF staining, and increased coexpression of HMGCR and CD163 in malignant high‐grade samples was found (Figure 8C,D and Figure S8A,B, Supporting Information).